Literature DB >> 12666108

Of mice and men: reconciling preclinical ALS mouse studies and human clinical trials.

Jeffrey D Rothstein.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12666108     DOI： 10.1002/ana.10561

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  25 in total

1.  Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials.

Authors:  Albert C Ludolph; Sarah Jesse
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

Review 2.  Catalytic antioxidants to treat amyotropic lateral sclerosis.

Authors:  John P Crow
Journal:  Expert Opin Investig Drugs       Date:  2006-11       Impact factor: 6.206

3.  The effects of diet composition on body fat and hepatic steatosis in an animal (Peromyscus californicus) model of the metabolic syndrome.

Authors:  Lisa Krugner-Higby; Stephen Caldwell; Kathryn Coyle; Eugene Bush; Richard Atkinson; Valerie Joers
Journal:  Comp Med       Date:  2011-02       Impact factor: 0.982

4.  Host induction by transplanted neural stem cells in the spinal cord: further evidence for an adult spinal cord neurogenic niche.

Authors:  Leyan Xu; Vasiliki Mahairaki; Vassilis E Koliatsos
Journal:  Regen Med       Date:  2012-11       Impact factor: 3.806

5.  Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice.

Authors:  Renzo Mancuso; Jaume del Valle; Laura Modol; Anna Martinez; Ana B Granado-Serrano; Omar Ramirez-Núñez; Mercé Pallás; Manel Portero-Otin; Rosario Osta; Xavier Navarro
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 6.  TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology.

Authors:  Iga Wegorzewska; Robert H Baloh
Journal:  Neurodegener Dis       Date:  2010-12-03       Impact factor: 2.977

7.  Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect.

Authors:  Marc Gotkine; Denise Kviatcovsky; Eran Elinav
Journal:  Gut Microbes       Date:  2020-06-05

Review 8.  Rodent models of TDP-43: recent advances.

Authors:  William Tsao; Yun Ha Jeong; Sophie Lin; Jonathan Ling; Donald L Price; Po-Min Chiang; Philip C Wong
Journal:  Brain Res       Date:  2012-05-01       Impact factor: 3.252

Review 9.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

10.  Current and emerging treatments for amyotrophic lateral sclerosis.

Authors:  Stefano Zoccolella; Andrea Santamato; Paolo Lamberti
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.